Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Zeldox development strategy disclosed

Aug. 20, 1998

Key U.S. patent issued for Emitasol

Aug. 20, 1998

GVS-111, a novel cognition-enhancing agent with a multifaceted mechanism of action

Aug. 20, 1998

French team synthesizes novel compounds with antihypoxic/antiischemic activity

Aug. 20, 1998

GR-196429 is a potent and selective agonist at melatonin receptors

Aug. 20, 1998

Akzo Nobel claims antipsychotic piperidine derivatives

Aug. 19, 1998

Elan subsidiary obtains patent rights for Cytel's integrin-blocking antibodies

Aug. 19, 1998

The Medicines Company acquires clinical-stage antimigraine drug for development

Aug. 18, 1998

Eisai files for Japanese approval of AD treatment agent

Aug. 17, 1998

Gidazepam, a new benzodiazepine anxiolytic with potential in asthenic disorders

Aug. 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...